Navigation Links
Unilabs Q1 2007/2008 Earnings Conference Call
Date:11/7/2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... 2014 (HealthDay News) -- Expert pilots process visual information ... they make better decisions during landings, a new study ... techniques for pilots to master, and 36 percent of ... occur during final approach and landing. Researchers monitored ... moderately experienced pilots while they were at the controls ...
(Date:12/15/2014)... 2014 Kathy McAfee, America's Marketing Motivator, ... Awards in the category of Best Blog 2014. McAfee ... her weekly career blog Networking Ahead which ... professionals elevate their talent and influence through better networking, ... her book Networking Ahead for Business, has been motivating ...
(Date:12/15/2014)... December 15, 2014 In support ... bring attention to restrictive state laws that may ... on this important area of public health policy. ... Compromise the Integrity of Independent Review, contends that ... of independent peer review determinations can result in ...
(Date:12/15/2014)... Bacteroides is becoming the indicator of choice ... more prevalent than coliforms, it cannot reproduce in the presence ... , Key Benefits of the new Bacteroides Sewage Screen:, ... Eliminates false positives from coliforms naturally occurring in the ... Maintain the same sampling method with results as ...
(Date:12/15/2014)... La Jolla, Calif. (PRWEB) December 15, 2014 ... Roasters made the Coffee Review “Top 30 Coffees of 2014.” ... number two, and their Guji Zone Ethiopia at number 10. ... list twice. , Coffee Review’s selection is ranked on ... The Sumatra Ulos Batak scored 96 out of 100, and ...
Breaking Medicine News(10 mins):Health News:Study Shows Why Expert Pilots Are Experts 2Health News:Kathy McAfee, America’s Marketing Motivator, Wins Best Blog from Women World Awards 2Health News:NAIRO Calls for Higher Quality Independent Peer Review By Ending Restrictive State Laws 2Health News:Bird Rock Coffee Roasters Ranks Second and Tenth in Coffee Review’s ‘Top 30 Coffees of 2014’ 2
... -- Home Health Equipment business sold in two ... debt reduction, additional working capital to fund DailyMed(TM) ... Amex: KAD ), a leading provider ... under the Arcadia HealthCare(SM) brand, today announced the ...
... TSX: COM,VANCOUVER, May 19 /PRNewswire-FirstCall/ ... today announced that the waiting period under the Hart-Scott-Rodino ... & Co., Inc. and a Merck affiliate for development ... treatment of atrial fibrillation, has expired, and the agreement ...
... Inc., headquartered in Orlando, FL, a leading provider ... predictive analytics, announced today that its solutions are ... the Centers for Medicare & Medicaid Services mandate, ... a medication therapy management (MTM) program.MEDai,s solutions ...
... -- Cylene Pharmaceuticals, Inc., announced today that ... their first-in-class, CK2 inhibitor CX-4945 at the 2009 BIO ... William G. Rice, Ph.D., Cylene,s president and CEO, will ... CX-4945, the Company,s oral protein kinase inhibitor currently in ...
... Donnica Moore Translates Sleep Facts from FictionWASHINGTON, May 19 ... today that, together with sanofi-aventis U.S., it has joined ... to debunk common myths and misperceptions about sleep. The ... Smart , which helps educate Americans about the importance ...
... social network the chance to meet one another and ... site, topics of interest to be discussed & members, ... www.FertilityTies.com ), the most comprehensive social network ... that combines expertise of accredited MDs, will bridge the ...
Cached Medicine News:Health News:Arcadia Resources Announces Sale of Non-Strategic Businesses 2Health News:Arcadia Resources Announces Sale of Non-Strategic Businesses 3Health News:Arcadia Resources Announces Sale of Non-Strategic Businesses 4Health News:Cardiome Announces That Collaboration and License Agreement with Merck & Co., Inc. Now Effective 2Health News:Cardiome Announces That Collaboration and License Agreement with Merck & Co., Inc. Now Effective 3Health News:MEDai Helps Medicare Part D Sponsors Adhere to CMS Medication Therapy Management Initiative 2Health News:Cylene to Announce New Data on Its First-in-Class Oral CK2 Inhibitor Against Cancer at BIO Conference 2Health News:Video: NSF Enlists Renowned Women's Health Expert to 'School' America on Sleeping Smart 2Health News:Video: NSF Enlists Renowned Women's Health Expert to 'School' America on Sleeping Smart 3Health News:Video: NSF Enlists Renowned Women's Health Expert to 'School' America on Sleeping Smart 4Health News:Video: NSF Enlists Renowned Women's Health Expert to 'School' America on Sleeping Smart 5Health News:FertilityTies.com Convention Open to the Public, June 6, 1-5 PM at The Hilton New York Hotel, MDs to Lead Discussion on Timely Fertility Topics 2
(Date:12/17/2014)... , Dec. 17, 2014  RXi Pharmaceuticals ... company focused on discovering, developing and commercializing innovative ... technologies, today announced completion of enrollment in its first ... the 3-month observations confirmed the 1-month findings that ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ...
(Date:12/15/2014)... Registreer nu via  http://bit.ly/ag8Sypm14de ... Februar sind alle akkreditierten pharmazeutischen Patientenversorgungsakten-Firmen (PMR) ... PROGRAMM ™ 2015 in Amsterdam ... Tagung soll dazu beitragen, der Aegate PMR ... profitablen Unternehmensdienstleistungen, die für Apotheken und die ...
(Date:12/15/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/32cmct/inferior_vena ... Vena Cava (IVC) Filters - Global Trends, Estimates and ... http://photos.prnewswire.com/prnh/20130307/600769 Global Inferior ... US$435 million by 2016. The North America ... global value while Europe claims ...
Breaking Medicine Technology:RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5Symposium über Aegates Ecosystem-Partner-Programm für sichere Medikamente vom 19. - 20. Februar 2015 in Amsterdam 2Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 2Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 3Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: